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ReceiVed October 7, 2005; ReVised Manuscript ReceiVed December 6, 2005
ABSTRACT: Acetyl-coA carboxylase (ACC) is a central metabolic enzyme that catalyzes the committed
step in fatty acid biosynthesis: biotin-dependent conversion of acetyl-coA to malonyl-coA. The bacterial
carboxyltransferase (CT) subunit of ACC is a target for the design of novel therapeutics that combat
severe, hospital-acquired infections resistant to the established classes of frontline antimicrobials. Here,
we present the structures of the bacterial CT subunits from two prevalent nosocomial pathogens,
Staphylococcus aureusandEscherichia coli, at a resolution of 2.0 and 3.0 Å, respectively. Both structures
reveal a small, independent zinc-binding domain that lacks a complement in the primary sequence or
structure of the eukaryotic homologue.
According to the Centers for Disease Control and Preven-
tion, the rates of severe, multidrug-resistant bacterial infec-
tions, including those caused by pathogens previously
confined to the hospital setting, have increased dramatically
in both hospital and community populations (1, 2). Both
Gram-positive [Staphylococcusaureus (Sa)1 andStreptococ-
cus pneumoniae] and Gram-negative [Escherichia coli(Ec)
and Pseudomonas aeruginosa] bacteria have ultimately
developed resistance to successive generations of clinically
useful antibiotics. The severity of microbial resistance is
underscored by the recent emergence of vancomycin-resistant
clinical isolates of methicillin-resistantSa, which are re-
sponsible for most of the severe hospital-acquired illnesses
(3-5). The ability to combat these organisms will therefore
require the development of pharmaceuticals against novel
cellular targets (6).
A subset of enzymes that catalyze bacterial type-II fatty
acid biosynthesis (FAS II), a pathway distinct from the
mammalian type-I system by virtue of its requirement for
de noVo fatty acid production and the structural divergence
of its key constituents, represent strong candidates for
antimicrobial drug design (7-9). Validation of the bacterial
FAS II system as a potential pathway for the selection of
novel targets is provided by anti-tubercular and broad-
spectrum antibacterial agents that selectively inhibit the
enoyl-ACP (acyl carrier protein) reductase-mediated reduc-
tion step of the FAS II elongation cycle (10-11). Additional
FAS-II-pathway antimicrobials blockâ ketoacyl-ACP syn-
thase (KAS) enzymes responsible for fatty acid chain
condensation (12-15). However, the design of enoyl-ACP
reductase and KAS inhibitors across bacterial species is
complicated by the presence of orthologous enzymes with
multiple isoforms and/or variable substrate specificities (7).
In contrast, the widespread conservation of bacterial acetyl-
CoA carboxylase (ACC), an essential enzyme that generates
the malonyl-CoA precursor required for the subsequent
condensation steps ofde noVo fatty acid synthesis, suggests
that ACC is an attractive FAS-II-pathway target. The
potential for ACC as an antibiotic target is demonstrated by
the recent discovery of the antibiotic Moiramide B and its
derivatives, the pyrrolidinediones, as potent inhibitors of
ACC (16, 17). Unfortunately, Moiramide B is not useful
clinically. Other compounds, including several classes of
well-established herbicides, the aryloxyphenoxypropionates
and cyclohexanediones, and a synthetic bisubstrate analogue
(BiSA) represent additional ACC-selective inhibitors (18,
19).
An assembly of protein constituents is required forin ViVo
ACC activity: biotinoyl carboxyl carrier protein (BCCP),
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aureusand E. coli have been deposited with the Protein Data Bank
(PDB accession codes 2F9I and 2F9Y, respectively).
* To whom correspondence should be addressed: 206 Life Sciences
Building, Baton Rouge, LA 70803. Telephone: 225-578-5209. Fax:
225-578-7258. E-mail: gwaldro@lsu.edu.
§ Vanderbilt University School of Medicine.
| These authors contributed equally to this work.
⊥ Pfizer Global Research and Development.
# Louisiana State University.
1 Abbreviations: ACC, acetyl-CoA carboxylase; BCCP, biotinoyl
carboxyl carrier protein; BC, biotin carboxylase; CT, carboxyltrans-
ferase; PCC, propionyl-CoA carboxylase; ACP, acyl carrier protein;
Ps 12S,Propionibacterium shermanii12S transcarboxylase;Sa, Sta-
phylococcus aureus; Ec, Escherichia coli; Sco, Streptomyces coelicolor;
Sc, Saccharomyces cereVisiae; FAS II, bacterial type-II fatty acid
biosynthesis; KAS, ketoacyl-ACP synthase; MMCoA, methyl-malonyl
CoA; BiSA, bisubstrate analogue; HS, helical subdomain.
1712 Biochemistry2006,45, 1712-1722
10.1021/bi0520479 CCC: $33.50 © 2006 American Chemical Society





























































































biotin carboxylase (BC), and carboxyltransferase (CT). These
components participate in the following partial reactions:
The biotinylated mobile arm of BCCP shuttles the biotin
cofactor from the site of BC-mediated, ATP-dependent
carboxybiotin production (1) into the site of CT-mediated
CO2 transfer from carboxybiotin to acetyl-CoA (2). In
eubacteria, protozoa, and plant chloroplasts, ACC activity
arises from a multisubunit assembly (prokaryotic ACC) of
monomeric biotin-BCCP, dimeric BC, and heterotetrameric
(R2â2) CT. In contrast, in fungi, animals, and plant cytosol,
each of these subunits function as distinct domains within a
single polypeptide (eukaryotic ACC) (20, 21). The two-step
carboxylase reaction mechanism and the structural organiza-
tion of the ACC multienzyme into distinct BC, BCCP, and
CT components is shared among members of the biotin-
dependent enzyme family, including propionyl-CoA car-
boxylase, transcarboxylase, glutaconyl-CoA decarboxylase,
and methylcrotonyl-CoA carboxylase (22). The lack of
primary sequence conservation observed between the prokary-
otic and eukaryotic forms of ACC and the major differences
in multi-enzyme subunit composition are features that can
potentially be exploited to inhibit specific partial reactions
of bacterial ACC without disruption of the mammalian
homologue.
Herein, we present the X-ray structures of the CT
component of bacterial ACC, a novel member of the
crotonase superfamily, from representative Gram-positive
(Sa) and Gram negative (Ec) species. Both structures possess
a unique zinc-binding domain that partially shelters the
acetyl-CoA binding site. This motif is conspicuously absent
in both the primary sequence of the eukaryotic enzyme and
the tertiary structure of the only eukaryotic ACC CT structure
(yeast) reported to date (23).
MATERIALS AND METHODS
Cloning, Expression, and Purification.The strategy for
overexpression of the genes coding for theR andâ subunits
of Sa and Ec CT has been described by Blanchard and
Waldrop (24). Because the genes for theR andâ subunits
are not contiguous on the genome, a mini-operon was
constructed to allow for overexpression of both genes.
Specifically, the genes corresponding to theR (residues
1-314) andâ (residues 1-285) subunits ofSa CT were
PCR-amplified from genomic DNA, ligated into pDEST-
T7-202, and transformed intoE. coli strain BL21-Gold
(DE3). After induction with 0.25 mM IPTG, expression was
carried out in a rich medium supplemented with 50µg/mL
kanamycin at 20°C for 20 h. A similar cloning protocol
was employed for the genes corresponding to theR (residues
1-319) andâ (residues 1-304) ofEcCT, with the exception
that the genomic amplification products were ligated into
pET14b and transformed into strain BL21(DE3)pLysS. After
induction with 3.2 mM IPTG, expression ofEc CT was
carried out in a rich medium supplemented with 100µg/mL
ampicillin and 34µg/mL chloramphenicol at 20°C for 15
h. In both cases, the cells were harvested by centrifugation
at 6722g for 30 min at 4°C. The pellets were lysed by
freeze-thaw/resuspension in 50 mM Tris-Base at pH 8.0,
10 mM MgCl2, 500 mM NaCl, and 1% Triton X-100 and
passage through a microfluidizer. The lysate was centrifuged
at 11000g for 1 h, and the supernatant was loaded onto a
Ni-NTA resin (Qiagen) pre-equilibrated in 50 mM Tris-Base
at pH 8.0 and 500 mM NaCl (buffer A). The CT subunits
were eluted with a linear imidazole gradient from 0 to 200
mM in buffer A (SaCT) or in a step to 200 mM imidazole
after a 20 mM imidazole wash (EcCT). Eluted CT (assessed
by SDS-PAGE) was dialyzed overnight in 10 mM KH2-
PO4 at pH 7.0 and 0.67 mM EDTA, transferred for a second
dialysis in 10 mM HEPES at pH 7.0 and 500 mM NaCl the
following day, and purified to homogeneity with a Hi-Load
26/60 Superdex 200 (Amersham) column pre-equilibrated
with 25 mM HEPES at pH 7.5 and 500 mM NaCl. In the
case ofEc CT only, the gel-filtration step was preceded by
cleavage and removal of the His tag through thrombin
(Sigma) digestion and passage over a Hi-Trap (Pharmacia)
chelating column charged with NiSO4 in 25 mM HEPES,
500 mM NaCl, and 20 mM imidazole at pH 7.5. The protein
was subsequently concentrated to 15 mg/mL and stored in
aliquots at-80 °C prior to crystallization.
Crystallization. SaCT orEcCT (each at 15 mg/mL) were
cocrystallized with BiSA (1 mM) under condition A (30%
PEG-400, 0.1 M HEPES at pH 8.0, and 0.2 M MgCl2 at 25
°C) or condition B (1 M NaH2PO4, 1 M K2HPO4, 0.2 M
Li2SO4, and 0.1 M CAPS at pH 9.5 and 4°C), respectively,
by the vapor diffusion method. TheSa CT condition
produced platelike crystals in 3-5 days. Hexagonal bipy-
ramidal Ec CT crystals grew over a similar time interval
under condition B.
X-ray Data Collection.Prior to data collection, CT crystals
were flash-frozen in liquid nitrogen immediately after transfer
to a solution of 10% ethylene glycol in mother liquor (Sa
CT) or after slow, incremental transfer to 6.25, 12.5, and
25% ethylene glycol in reservoir solution (EcCT). Complete
data sets forSaCT andEc CT were collected at 100 K to
1.98 and 3.2 Å, respectively, at the Industrial Macromolecular
Crystallography Association Collaborative Access Team
(IMCA-CAT) beam-line 17-ID at the Advanced Photon
Source (Argonne National Laboratory). All data were
processed with HKL2000 (38). Diffraction images were
processed and scaled using the Denzo/HKL suite (37). Data
collection statistics are shown in Table 1.
Structure Determination and Refinement.The structure of
Sa CT was solved by molecular replacement in CNS (39)
with a dimeric polyalanine search model derived from the
Ps 12S hexamer (PDB ID 1ON3, chains A and D). A
monomer of the search model corresponds to a tandem
domain repeat, and each of the structurally homologous
domains shares<15% sequence identity with theR andâ
subunits of Sa CT. The search model (the dimer that
corresponds to aR2â2 tetramer) was positioned in the
asymmetric unit to give a correlation coefficient of two
standard deviations above the mean. Placement of a single
dimeric model is consistent with the noncrystallographic
symmetry of the Patterson and a Matthew’s coefficient (Vm
) 2.4 Å3/Da) in the generally observed range. After rigid-
body, energy-minimization, and simulated-annealing refine-
HCO3
- + ATP + BCCP-biotin {\}
BC, Mg2+
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ment in CNS (Rwork/Rfree ) 52/53) of the polyalanine model,
a σA-weighted, 2Fo - Fc electron-density map calculated
over the full resolution range (50-1.98 Å) revealed inter-
pretable side-chain density for a number of conserved
residues in the central core of the model.
A noncrystallographic symmetry matrix, assigned with the
assumption that the monomer pseudo-2-fold of the 12S
search model corresponds to anRâ dimer pseudo-2-fold in
the Sa CT tetramer, was used to calculate an averaged,
solvent-flattened electron-density map with DM (40) in CCP4
(41). The map revealed clear side-chain electron density at
or near the dimer interface. Automated chain tracing and
refinement with ARP-wARP (42) (CCP4) increased the
extent of an initial model (from 11 to 80% of the protein)
and resulted in anRwork/Rfree of 20/26. After further cycles
of model building in O (43) and refinement in Refmac 5
(CCP4;44) over the entire resolution range, the final model
of SaCT has anRwork/Rfree of 18.9/21.0 and consists of 92%
(1120/1224) of the full-length sequence, 2 Zn2+, and 583
waters (Table 1). The remaining 8% ofSaCT localizes to a
22-residue disordered stretch at the far N terminus of theâ
subunit and to a 10-residue gap between solvent-exposed
helices at the N terminus ofR. A simulated annealing
composite omit map calculated in CNS and contoured at 1σ
reveals additional nonprotein electron density in the active
site that we tentatively assign to an undetermined portion of
the BiSA inhibitor.
A molecular replacement strategy forEc CT was subse-
quently initiated with a polyalanine search model derived
from the refinedSa CT structure. Dimeric and tetrameric
search models were tested in each of several possible
hexagonal space groups. A solution [using Molrep (CCP4)]
was obtained inP6522 (Vm ) 5.0 Å3/Da, 75% solvent) with
the Râ dimer as a search model (45). In this space group,
crystallographic symmetry operators generate the biological
heterotetramer from a singleRâ dimer in the asymmetric
unit. One cycle of rigid-body, energy-minimization, and
simulated-annealing refinement in CNS produced a map with
interpretable side-chain density for approximately 80% of
the Ec CT primary sequence (Rwork/Rfree ) 42/46). In
conjunction with model building in O and overall isotropic
B-factor refinement in CNS, further cycles of energy-
minimization and simulated-annealing refinement were con-
ducted until theRfree decreased below 30%. At this stage,
seven water molecules were added and a final round of
B-group and simulated-annealing refinement was performed
(Table 1). The backbone trace of the finalEc CT model
(Rwork/Rfree ) 25/29) superposes well [root-mean-square
deviation (rmsd) 1 Å] with the Sa CT model and lacks
density in similar regions of the structure. There are
additional poorly defined stretches encompassing residues
88-98 and 234-238 of theâ monomer.
X-ray Fluorescence Measurements.Single-crystal and
solution-state X-ray fluorescence data were collected at the
Protein Crystallography MAD and the Double Crystal
Monochromator beamlines, respectively, at the Center for
Advanced Microstructures and Devices (Baton Rouge, LA).
Fluorescence emission spectra were recorded over an incident
energy range of 9640-9680 eV on a singleSaCT crystal
grown as described above and frozen at 100 K in a
cryosolution of 20% ethylene glycol in mother liquor.
Dispersive fluorescence measurements at an excitation energy
of 10.5 keV were collected over an emission range of 1-20
keV at room temperature on a solution of apoSa CT
concentrated to 50 mg/mL in 10 mM HEPES at pH 7.0 and
500 mM NaCl. Spectra were acquired on the empty sample
cuvette under identical conditions as a control for background
emission from trace elements.
RESULTS AND DISCUSSION
OVerall Fold. The crystal structures of the carboxyltrans-
ferase components of acetyl-CoA carboxylase fromSaand
Ecwere solved to resolutions of 2.0 and 3.2 Å, respectively.
Both structures confirm theR2â2 heterotetrameric assembly
determined by gel-filtration and sedimentation equilibrium
analysis of the purifiedEc enzyme (25). The bacterial CT’s
share 52% sequence identity, and the tetramers superimpose
with a rmsd of 1 Å over 93% of the backbone trace (unless
otherwise noted, theEc residue numbering employed through-
out the text refers to residues conserved between both
species). The overall structure of the tetramer is a truncated
rectangular pyramid with its base at 72× 88 Å, apex at 23
× 34 Å, and height at 52 Å (parts a, b, and d of Figure 1).
The oligomer is a dimer of dimers related by a 2-fold axis
that runs through a central cavity that gradually narrows from
a 13 Å diameter opening to a solvent-inaccessible surface
at a depth of 23 Å. Two distinct interfaces are generated by
structurally homologous, wedge-shapedR andâ monomers
that occupy roughly equivalent volumes at the four corners
Table 1: X-ray Data Collection and Refinement Statistics
SaCT EcCT
data collection
resolution range (Å) 50-1.98 30-3.2
total/unique reflections 273 345/90 018 183 454/23 565
completeness (%) 98 (82)a 100 (100)
redundancy 3.0 (2.7) 7.8 (8.0)
I/σ 17.5 (3.4) 26.6 (4.1)
Rmerge(%)b 6.0 (29.3) 6.8 (41.2)
refinement
resolution range (Å) 50-1.98 30-3.2
number of reflections 80 987 22 030
σ cutoff none none
R factor (%)c 18.9 24.7
Rfree (%)d 21.0 28.7









B from Wilson plot 31.7 N/A
rmsd
bonds (Å) 0.016 0.007
angles (deg) 1.4 1.4
Ramachandran plot
most favorable 91.2 75.5
additional allowed 8.7 23.7
disallowed (%) 0.1 0.8e
a Values in parentheses refer to the highest resolution shell.b Rmerge
) ∑hkl∑i|Ihkl - 〈I〉hkl|/∑hkl∑i〈I〉hkl, whereIhkl is the intensity measurement
for a given reflection and〈I〉hkl is the average intensity for multiple
measurements of this reflection.c R factor) ∑|Fo,hkl - Fc,hkl|/∑(Fo,hkl)
× 100, whereFo,hkl is the observed structure factor amplitude andFc,hkl
is the calculated structure factor amplitude.d Rfree was calculated from
5% of the diffraction data and monitored throughout refinement.
e Outliers observed in regions of poorly defined density.
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of the pyramid (parts a and b of Figure 1). The first consists
of a “weak” Râ interface (∼4000 Å2 of buried surface)
situated on the vertical plane bisecting the short axes of the
pyramid (parts c and d of Figure 1). The second entails a
“strong” Râ interface (∼9000 Å2 of buried surface) in which
the triangular faces of the monomers are juxtaposed on a
60° incline (parts e and f of Figure 1).
The structurally similarR and â monomers (A and B)
possess anR/â spiral core composed of a long, twisted, and
tapered 7-stranded mixedâ sheet (Aâ1-5/Bâ5-9, Aâ6/
Bâ11, and Aâ8/Bâ13) orthogonal to a short, 2-stranded
parallelâ platform (Aâ5/Bâ10 and Aâ7/Bâ12) (Figure 2).
The 7-strandedâ sheet is flanked by helical regions (AR12/
BR9 and AR4/BR2) and a 3-helix bundle of AR6/BR4, AR7/
FIGURE 1: Overall fold ofSaCT. (a) Stereo ribbon representation of theR2â2 heterotetramer. TheR andâ monomers are colored in green
and purple, respectively. (b) Schematic representation of theR2â2 heterotetramer in a as a truncated rectangular pyramid viewed from
above. The markings - - - and‚‚‚ indicate the position of the “weak” and “strong”Râ tetramer interfaces, respectively. The annotation‚‚‚
also indicates a field out of direct view. (c and d) Perspective along the “weak”Râ interface in which the tetramer in a and the tetramer
schematic in b have been rotated 90° about thex axis (see large dotted arrow), respectively. TheRâ dimer, which lies behind thisRâ face
has been removed for clarity. (e and f) Perspective along the “strong”Râ interface in which the tetramer in c and the tetramer schematic
in d has been rotated 90° about they axis (see small dotted arrows), respectively. TheRâ dimer, which lies behind thisRâ face has been
removed for clarity. a, c, and e were produced in Molmol (46) and rendered in Povray (47). These programs were used to create all ribbon
displays presented in this paper.
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BR5, and AR8/BR6. These helical elements constitute
pseudosymmetrical edges of the triangular face of the wedge.
Both sets of helices converge toward the apex of this triangle,
and the 3-helix bundle provides the primary scaffold for the
2-stranded platform at its base. The structure-based sequence
alignment in Figure 3 highlights (1) the extensive structural
homology of the spiralR/â monomer fold to enoyl-CoA
hydratase (crotonase) and (2) the presence of an oxyanion
hole (G204-G205) for CoA-thioenolate stabilization as
described for other members of the crotonase superfamily.
Both of these elements, which are maintained through
divergent evolution, place the bacterial CT subunits into this
enzyme subcategory (26). This classification was originally
predicted by Murzin on the basis of sequence alignments
(27).
The ActiVe Site.A “ridges in grooves”-type stacking of
conserved hydrophobic residues between the AR7-8 (I181,
L185, and L209) and BR5-6 (L174, M177, and A208)
helices generates a 6-helix bundle at the “strong”Râ interface
(Figure 4). This packing arrangement orients the triangular
FIGURE 2: Structure of theSaCT R andâ monomers andRâ dimer. Schematic drawing in stereo of the structure of (a) theR monomer
(residues 1-18 and 30-314), (b) theâ monomer (residues 26-285), and (c) theRâ dimer. The secondary structural elements are labeled.
In the text, these labels are appended with “A” (representing theR monomer) or “B” (representing theâ monomer).
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faces of dimer partners on a 60° tilt with respect to one
another and effectively doubles the length of theâ-strand
platform by positioning the hairpins from individual mono-
mers on opposite sides of a pseudo-2-fold axis (Figure 4).
Because conserved residues found on and surrounding this
platform are located in the liganded active sites of other
FIGURE 3: Structure-based sequence alignment ofEc and Sa CT R/â monomers withScoCT domains and crotonase. Color coding of
sequences:Ec/SaR (light green),Scodomain 1 (dark green),Ec/Saâ (light purple), Sco domain 2 (dark purple), and crotonase (blue).
Sequences are numbered according to theEc R/â monomers, and secondary structural elements corresponding to theSa R/â monomers
(above the alignment) or crotonase (below the alignment) are color-coded according to the scheme employed for theSa/Ec monomer or
crotonase sequences. Secondary structural elements within the structurally homologous spiral core domains ofSa/Ecm nomers, and crotonase
is surrounded by a bold solid line. Within this outline, residues that constitute the conserved oxyanion holes that recognize the biotin ureido
enolate or CoA thioenolate intermediates are boxed in black. The invariant cysteinyl zinc ligands in CTâ are boxed in red. Residues inEc
R (22-38, 41, 46, and 52-53) andEc â (93-98 and 285-204) that are not visible or lack clear side-chain density are absent or modeled
as alanine, respectively. This figure was produced using STRAP (48) and Alscript (49).
Crystal Structure of Carboxyltransferase Biochemistry, Vol. 45, No. 6, 20061717
FIGURE 5: Pseudo-2-foldSaCT active-site platform in theRâ catalytic dimer. The interlockingR (green) andâ (purple) monomers as
viewed from a perspective above the catalytic platform. Centrally located, secondary structural elements that create the pseudo-2-fold
through the active site are colored in orange inR and cyan inâ. The acetyl-CoA substrate and biocytin product are modeled in the active
site on the basis of the superposition with theScoCT structure (28). Access/exit routes for substrates/products in the CT reaction are
labeled as GAPS A, B, and C.
FIGURE 4: Structure of theSaCT Râ catalytic dimer. Ribbon representation of the complex between theR (green) andâ (purple) monomers
along the “strong” interface. The pseudo-2-fold equivalent helices or strands that generate the 6 helix bundle or catalytic platform, respectively,
are labeled in orange inR and cyan inâ. The annotation - - - indicates the helices encompassed by HS1, and the annotation‚‚‚ indicates
the interdomain tilt angle. The inset is a schematic diagram of the ribbon representation.
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biotin-dependent carboxylases, including the substrate-bind-
ing clefts ofStreptomyces coelicolor(Sco)/Saccharomyces
cereVisiae(Sc) CT (23, 28) andPropionibacterium shermanii
12S transcarboxylase (Ps12S) (29), we will henceforth refer
to this site as the “catalytic platform” (Figure 4).
The structurally equivalent overall folds of theR and â
subunits suggest duplication and divergence of a single
ancestral CT subunit gene. However, an inherent asymmetry
in the structural homology of theR andâ subunits allows
for the creation of distinct biotin and acetyl-CoA-specific
subsites. When viewed from a perspective above theRâ
interface, theR andâ subunits possess structurally disparate
motifs that project toward the viewer. As shown in Figure
4, four subdomains [2 helical domains from theR subunit
(designated helical subdomain (HS) 1R and 2R (ΗS1R and
HS2R) and a Zn-binding domain and helical domain from
the â monomer (HS1â)] coalesce to provide a canopy over
the catalytic platform where three portals (labeled gaps A,
B, and C in Figure 5) in the canopy appear to provide active-
site access. The regions that flank these portals break the
symmetry of the active site that would result if the structural
homology of theR or â subunits extended over the entire
FIGURE 6: Sa CT active site. A stereo representation of a composite omit 2Fo - Fc electron-density map (violet) contoured at 1σ and
calculated for the refinedSaCT model in the region of the central pseudo-2-fold of the active site. Residue labels corresponding to amino
acids fromSaCT R andâ are colored black and green, respectively. Centrally positioned, nonprotein electron density ascribed to BiSA is
proposed to interfere with acetyl-CoA access to the G207-G208 oxyanion hole of CTâ.
FIGURE 7: SaCT binds zinc with an atypical zinc ribbon motif. (a) X-ray fluorescence scan of a singleSaCT crystal reveals the characteristic
Zn K-edge profile. (b) Dispersive X-ray fluorescence spectra of a cuvette blank (red solid line) and solution-stateSaCT as purified (black
solid line) show a clear peak at the Zn K-edge. (c) Side-by-side ribbon representations of the Zn ribbon motif ofSaCT-â and the “classical”
Zn ribbon from the 50S ribosomal protein L37Ae of the halophilic archaebacteriumHaloarcula marismortui.
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protein. The portals may serve as “traffic control” elements
that coordinate active-site access for substrates constrained
by bulky carrier groups: biotinoyl carboxyl carrier protein
and coenzyme A.
Two key conserved residues in the active site, G206 and
G207, are located in the consensus sequence 206-GGXX-
HHH-212 (where X) a small residue, H) hydrophobic),
which is at the N terminus of AR8 (Figure 3). The peptidic
hydrogens of G206 and G207 form a conserved oxyanion
hole at the base of this helix that is proposed to stabilize a
ureido enolate that forms during decarboxylation of car-
boxybiotin N1 in the homologous CT subunit of propionyl-
CoA carboxylase (PCC) fromSco (28). Similarly, a con-
served oxyanion hole in theâ subunit is formed by G204
and G205 at the N terminus of BR6 (Figure 3). The peptidic
hydrogens of this glycine pair in theSco PCC structure,
which correspond to the conserved oxyanion hole in croto-
nase, were found to act as hydrogen-bond donors to the
carbonyl of the methyl-malonyl-CoA (MMCoA) ligand and
proposed to stabilize the developing negative charge on the
enolate intermediate (28).
It is important to note thatSaCT was crystallized in the
presence of a BiSA inhibitor that combines features of both
substrates: coenzyme A is covalently linked to carboxybiotin
(19). However, continuous electron density consistent with
the intact inhibitor is not apparent (Figure 6). This absence
of density could be a consequence of hydrolysis of the
analogue in the course of the crystallization or could simply
reflect a lack of specific contacts over the length of the
inhibitor in our crystallization conditions. Inspection of a 2Fo
- Fc composite omit map reveals nonprotein density that
likely corresponds to a portion of the inhibitor in a
hydrophobic region of the active site at the central pseudo-
2-fold of the catalytic platform (Figure 6). In the structure
of MMCoA/biocytin-boundSco PCC, a biotin-dependent
carboxyltransferase whose acyl-CoA substrate differs from
acetyl-CoA by the addition of a methyl group, the position
of the acyl thioester of MMCoA is in close proximity to the
density that we tentatively attribute to the BiSA inhibitor.
This density predominantly covers the hydrophobic cavity
that presents the helical dipole and oxyanion hole (G207-
G208 of BR6 in SaCT) to the acyl thioester of MMCoA.
Mutations in Sa or Ec CT that confer resistance to the
pyrollidine dione derivative CPD2 (16) localize to two highly
conserved residues that are either nearby (G203A inSaCTR)
or within (S207Y in Ec CTâ) consensus sequences that
define this oxyanion hole.
The Zn Domain: A Unique Feature of the Prokaryotic
Enzyme.While the overall fold of bacterial CT confirms that
it is indeed a member of the crotonase superfamily, a
surprising and novel feature of the enzyme is the Zn domain
(Figure 7c). EarlyFo - Fc maps calculated for theSaCT
structure revealed a 20σ peak encapsulated by a tetrahedral
arrangement of sulfurs contributed by the cysteine residues
that terminate Bâ1(C27)/Bâ3(C46) and those immediately
preceding Bâ2(C30)/Bâ4(C49) (Figure 3). X-ray fluores-
FIGURE 8: Sa/Ec CT active site presents a markedly electropositive surface by comparison to other CT structures. Electrostatic surface
renderings for theSa/Ec CT tetramers and theSco/ScCT dimers are contoured from-5 (red) to 0 (white) to+5 (blue) kT/E. Only one of
the two pseudosymmetrically related active sites is indicated for each structure. Electrostatic potentials were calculated using Grasp (50)
and surface-mapped and rendered in VMD (51).
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cence spectra collected on solution-state and crystalline
preparations ofSaCT in its apo form demonstrate that the
peak corresponds to Zn2+ (parts a and b of Figure 7).
Sequence alignment of the CTâ primary sequence with
orthologous enzymes from eubacteria, algae, plants, and
animals reveals that the cysteine ligands are invariant residues
within an independent N-terminal domain that exists in
prokaryotic but not eukaryotic CT. The Zn motif in CTâ is
an atypical Cys4 “zinc ribbon” that most closely resembles
the Zn-binding structures observed in ribosomal proteins
(Figure 7c; PDB code 1jj2), RNA polymerase II subunits
(1i5b) and the basal transcription factors TFIIS(1tfi) and
TFIIB(1pft). Unlike the classical motif in which the second
sheet is three-stranded and significantly longer than the first
(30), the fold in CTâ bears an intervening helix between
two shortâ hairpins (Figure 7c).
The inner face of the CTâ Zn-binding domain forms
roughly half of an electropositive, hemicircular surface that
encompasses residues from both subunits (Figure 8). A
comparison of the electrostatic properties ofEc/SaCT with
the structurally homologous carboxyltransferasesScCT and
ScoPCCB reveals thatEc/SaCT possess a greater overall
net positive charge at pH 7 (EcCT ) +4, SaCT ) -16,Sc
CT ) -26, andScoCT ) -42). Zn domains are commonly
associated with DNA-binding proteins, and preliminary
studies using electrophoretic mobility shift assays indicate
thatEcCT does indeed bind DNA (data not shown). Studies
to determine the DNA-binding specificity ofEc CT, if any,
are underway.
In addition to nucleic-acid-binding functions, Zn ribbon
structures have also been found to constitute catalytically
essential, active-site “lids” in isoleucyl-tRNA synthetase,
methionyl-tRNA synthetase, and the histone deacetylase
silent information regulator 2 (31-35). In this regard, it is
noteworthy that theâ subunit of the prokaryoticR2â2 CT
heterotetramer isolated from plant chloroplast, which aligns
over the primary sequence of both bacterial CT subunits
(39%/47% identity between pea andEc CT-â/R), bears the
zinc finger consensus C-X2-C-X15-C-X2-C (35). Dele-
tion of the Zn finger motif in plastidic CT completely
abrogates enzymatic activity, while mutagenesis of the four
individual cysteines to alanine produces an enzyme that
exhibits<20% wild-type activity (36). Because phylogenetic
evidence indicates that plastidic ACC subunit genes are
derived from a cyanobacterial endosymbiont and the site of
plant lipid biosynthesis resides within the choroplast, these
observations suggest the possibility that the prokaryotic CT
Zn domain participates in a conserved activity related to fatty
acid synthesis initiation (37).
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